Pacira Biosciences
PCRX
#5673
Rank
HK$9.19 B
Marketcap
HK$204.64
Share price
2.18%
Change (1 day)
32.93%
Change (1 year)
Categories

Market capitalization of Pacira Biosciences (PCRX)

Market cap: HK$9.19 Billion

As of December 2025 Pacira Biosciences has a market cap of HK$9.19 Billion. This makes Pacira Biosciences the world's 5673th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Pacira Biosciences from 2011 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$9.19 B30.54%
2024HK$7.04 B-42.44%
2023HK$12.23 B-11.59%
2022HK$13.84 B-33.77%
2021HK$20.89 B3.7%
2020HK$20.15 B36.31%
2019HK$14.78 B6.47%
2018HK$13.88 B-4.02%
2017HK$14.46 B54.46%
2016HK$9.36 B-57.28%
2015HK$21.93 B-11.78%
2014HK$24.86 B65.79%
2013HK$14.99 B239.44%
2012HK$4.41 B281.65%
2011HK$1.15 B

End of Day market cap according to different sources

On Dec 12th, 2025 the market cap of Pacira Biosciences was reported to be:

HK$8.80 Billion
by Nasdaq info icon info icon
HK$9.19 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Recro Pharma
REPH
HK$0.95 B-89.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
HK$3.57 B-61.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
HK$63.13 M-99.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
HK$1.95 B-78.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
HK$5.60 B-39.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
HK$11.67 B 27.00%๐Ÿ‡บ๐Ÿ‡ธ USA